相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study
Nicolas Margot et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Lenacapavir: a first-in-class HIV-1 capsid inhibitor
Hadas Dvory-Sobol et al.
CURRENT OPINION IN HIV AND AIDS (2022)
Lenacapavir effective in multidrug-resistant HIV infections
Susanne Krome
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2022)
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
Sorana Segal-Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes
Nicolas Margot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Edgar T. Overton et al.
LANCET (2020)
Structural and mechanistic bases for a potent HIV-1 capsid inhibitor
Stephanie M. Bester et al.
SCIENCE (2020)
HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
Paul Spearman
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa
Stephen D. Lawn et al.
AIDS (2009)